• KalVista's rival to Takeda's Firazyr aces trial, sending stock up 200%

    21 days ago - By Fierce Biotech

    KalVista's rival to Takeda's Firazyr aces trial, sending stock up 200% ntaylor
    Tue, 02/09/2021 - 08:07
    Read more ...